A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : DOX / doxorubicin

[Related PubMed/MEDLINE]
Total Number of Papers: 9106
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   DOX  (>> Co-occurring Abbreviation)
Long Form:   doxorubicin
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2021 131I-Labeled Multifunctional Polyethylenimine/Doxorubicin Complexes with pH-Controlled Cellular Uptake Property for Enhanced SPECT Imaging and Chemo/Radiotherapy of Tumors. APAS, HPAO, PEG, PEI, SPECT
2021 3',4'-Dihydroxyflavonol Modulates the Cell Cycle in Cancer Cells: Implication as a Potential Combination Drug in Osteosarcoma. DiOHF, OS
2021 3D MXene microspheres with honeycomb architecture for tumor photothermal/photodynamic/chemo combination therapy. NIR
2021 3D Printed Bioceramic Scaffolds as a Universal Therapeutic Platform for Synergistic Therapy of Osteosarcoma. PDLLA, TCP
2021 3D printing-based drug-loaded implanted prosthesis to prevent breast cancer recurrence post-conserving surgery. PTX
2021 8-Formylophiopogonanone B antagonizes doxorubicin-induced cardiotoxicity by suppressing heme oxygenase-1-dependent myocardial inflammation and fibrosis. 8-FOB, GEO
2021 A carboxymethyl lentinan layer by layer self-assembly system as a promising drug chemotherapeutic platform. Hela, LbL, LC, MSNs, PLO
2021 A Combined Bioinformatic and Nanoparticle-Based Study Reveal the Role of ABCG2 in the Resistance of Breast Cancer. ABCG2, ER, HER2, PR, siRNA
2021 A comprehensive review on alginate-based delivery systems for the delivery of chemotherapeutic agent: Doxorubicin. DDS
10  2021 A dual-functional biomimetic-mineralized nanoplatform for glucose detection and therapy with cancer cells in vitro. FRET, GOx, m-CaCO3-PDA NPs, TME
11  2021 A glutathione-responsive polyphenol - Constructed nanodevice for double roles in apoptosis and ferroptosis. ROS, TA
12  2021 A Microfluidic Multisize Spheroid Array for Multiparametric Screening of Anticancer Drugs and Blood-Brain Barrier Transport Properties. BBB, CIS
13  2021 A MnO2-coated multivariate porphyrinic metal-organic framework for oxygen self-sufficient chemo-photodynamic synergistic therapy. PDT, ROS
14  2021 A multifunctional nanodiamond-based nanoplatform for the enhanced mild-temperature photothermal/chemo combination therapy of triple negative breast cancer via an autophagy regulation strategy. APZ, FL, HA, ICG, ND, PA, PS, PTT, TNBC
15  2021 A nanocellulose-based platform towards targeted chemo-photodynamic/photothermal cancer therapy. CNCs
16  2021 A nanoselenium-coating biomimetic cytomembrane nanoplatform for mitochondrial targeted chemotherapy- and chemodynamic therapy through manganese and doxorubicin codelivery. GPX4, ROS, SOD1
17  2021 A New Chalcone Derivative C49 Reverses Doxorubicin Resistance in MCF-7/DOX Cells by Inhibiting P-Glycoprotein Expression. MDR
18  2021 A new combination strategy to enhance apoptosis in cancer cells by using nanoparticles as biocompatible drug delivery carriers. Epo, NPs
19  2021 A New Water-Soluble Thermosensitive Star-Like Copolymer as a Promising Carrier of the Chemotherapeutic Drug Doxorubicin. D-g-PNIPAM, DLS, FTIR
20  2021 A novel immunochemotherapy based on targeting of cyclooxygenase and induction of immunogenic cell death. 5-ASA, COX, FASA, PASA, PGE2
21  2021 A Novel Integrated Pharmacokinetic-Pharmacodynamic Model to Evaluate Combination Therapy and Determine In Vivo Synergism. PK, Sor
22  2021 A novel multifunctional NCQDs-based injectable self-crosslinking and in situ forming hydrogel as an innovative stimuli responsive smart drug delivery system for cancer therapy. HA, NCQD
23  2021 A novel theranostic nanoplatform for imaging-guided chemo-photothermal therapy in oral squamous cell carcinoma. NIR, OSCC, PDA, R/G, ROS
24  2021 A pH-Responsive Supramolecular Drug Delivery System Constructed by Cationic Pillar[5]arene for Enhancing Antitumor Activity. SDS
25  2021 A pH-sensitive drug delivery system based on hyaluronic acid co-deliver doxorubicin and aminoferrocene for the combined application of chemotherapy and chemodynamic therapy. AFC, CDT, CT
26  2021 A pH-sensitive nanocarrier based on BSA-stabilized graphene-chitosan nanocomposite for sustained and prolonged release of anticancer agents. BSG
27  2021 A pH-Sensitive Self-Assembled and Carrier-Free Nanoparticle Based on Charge Reversal for Enhanced Synergetic Chemo-Phototherapy. DDS, FL, NPs, PA, ZnPc
28  2021 A promising dual-drug targeted delivery system in cancer therapy: nanocomplexes of folate-apoferritin-conjugated cationic solid lipid nanoparticles. AFr, cSLN, DTPLNs, FA, MTO, TEM, TPNs
29  2021 A prospective survey study of lower urinary tract dysfunction in childhood cancer survivors after vincristine and/or doxorubicin chemotherapy. DVSS, LUTD, VCR
30  2021 A Self-Assembling Amphiphilic Peptide Dendrimer-Based Drug Delivery System for Cancer Therapy. AmPDs
31  2021 A small molecule nanodrug consisting of pH-sensitive ortho ester-dasatinib conjugate for cancer therapy. ---
32  2021 A Synergistic Combination of Niclosamide and Doxorubicin as an Efficacious Therapy for All Clinical Subtypes of Breast Cancer. Nic
33  2021 A Targeted Erythrocyte Membrane-Encapsulated Drug-Delivery System with Anti-osteosarcoma and Anti-osteolytic Effects. VEGF, ZA
34  2021 A Targeted Nano Drug Delivery System of AS1411 Functionalized Graphene Oxide Based Composites. CO, gamma-PGA, GO
35  2021 A traceable, GSH/pH dual-responsive nanoparticles with spatiotemporally controlled multiple drugs release ability to enhance antitumor efficacy. CA-4, CPT
36  2021 A triple-targeting delivery system carrying two anticancer agents. Az
37  2021 A tumor extracellular pH-sensitive PD-L1 binding peptide nanoparticle for chemo-immunotherapy of cancer. ICD, NPs
38  2021 A versatile gas-generator promoting drug release and oxygen replenishment for amplifying photodynamic-chemotherapy synergetic anti-tumor effects. HMSNs, ICG, PDA, PDT, PFP, ROS
39  2021 Acid-Responsive Adamantane-Cored Amphiphilic Block Polymers as Platforms for Drug Delivery. ---
40  2021 Acid-Responsive and Biologically Degradable Polyphosphazene Nanodrugs for Efficient Drug Delivery. EPR, PPZ
41  2021 Acid-Sensitive Supramolecular Nanoassemblies with Multivalent Interaction: Effective Tumor Retention and Deep Intratumor Infiltration. TME
42  2021 Acid-triggered degradable polyprodrug with drug as unique repeating unit for long-acting drug delivery with minimal leakage. Boc-AH
43  2021 Activation of Nrf2 by miR-152 Inhibits Doxorubicin-Induced Cardiotoxicity via Attenuation of Oxidative Stress, Inflammation, and Apoptosis. miRNAs
44  2021 Active stealth and self-positioning biomimetic vehicles achieved effective antitumor therapy. MSCs, MSN
45  2021 Additive effects of resveratrol and doxorubicin on bladder cancer cells. NDI, RES
46  2021 aFGF Targeted Mediated by Novel Nanoparticles-Microbubble Complex Combined With Ultrasound-Targeted Microbubble Destruction attenuates Doxorubicin-Induced Heart Failure via Anti-Apoptosis and Promoting Cardiac Angiogenesis. BNP, EF, FS, HF, UTMD
47  2021 Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats. cTnI, MDA, QTc, SOD, TAC, TNF-alpha
48  2021 Albumin-Based Nanoparticles for the Delivery of Doxorubicin in Breast Cancer. BSA, Glu, HSA, SPDP
49  2021 Aldose reductase regulates doxorubicin-induced immune and inflammatory responses by activating mitochondrial biogenesis. AR
50  2021 Algerian propolis: between protection of normal cells and potentialisation of the anticancer effects of doxorubicin against breast cancer cells via P-glycoprotein inhibition and cell cycle arrest in the S phase. P-gp
51  2021 Alpha-lipoic acid may ameliorate testicular damage by targeting dox-induced altered antioxidant parameters, mitofusin-2 and apoptotic gene expression. ALA
52  2021 An antibody against L1 cell adhesion molecule inhibits cardiotoxicity by regulating persistent DNA damage. ECs
53  2021 An Electrochemical Strategy for the Simultaneous Detection of Doxorubicin and Simvastatin for Their Potential Use in the Treatment of Cancer. SMV
54  2021 An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells. CC, CUR, EE, EPR
55  2021 An Integrated Tumor Microenvironment Responsive Polymeric Micelle for Smart Drug Delivery and Effective Drug Release. TME
56  2021 An iron oxide nanoparticle-based transdermal nanoplatform for dual-modal imaging-guided chemo-photothermal therapy of superficial tumors. DiR, SPIO, TD
57  2021 An MRI-guided targeting dual-responsive drug delivery system for liver cancer therapy. LA, MRI, UV
58  2021 An mTOR and VEGFR inhibitor combination arrests a doxorubicin resistant lung metastatic osteosarcoma in a PDOX mouse model. OS-PDCs, PDOX
59  2021 An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity. FAK, HER2, MAPK, PI3K
60  2021 Andiroba oil and nanoemulsion (Carapa guianensis Aublet) reduce lesion severity caused by the antineoplastic agent doxorubicin in mice. AN, AO, i.p
61  2021 Angiopep-2-Modified Carboxymethyl Chitosan-Based pH/Reduction Dual-Stimuli-Responsive Nanogels for Enhanced Targeting Glioblastoma. ANG, BBB, CMCSN, GBM
62  2021 Antennapedia-derived positively-charged peptide faces multiple problems upon their usage as targeting ligand for liposomal doxorubicin. ---
63  2021 Anthocyanins from purple sweet potato alleviate doxorubicin-induced cardiotoxicity in vitro and in vivo. CK, HPLC-MS, LDH, PSPA, TMAO
64  2021 Anthracycline-free tumor elimination in mice leads to functional and molecular cardiac recovery from cancer-induced alterations in contrast to long-lasting doxorubicin treatment effects. GCV
65  2021 Anti myelosuppressant and hematopoietic activities of ethanolic fraction obtained from seeds of Carica papaya L. ---
66  2021 Anti-CD19 mAb modified mesoporous titanium dioxide as exclusively targeting vector for efficient B-lymphoblastic leukemia therapy. B-LL, MTNs
67  2021 Anti-oxidant impact of Lisinopril and Enalapril against acute kidney injury induced by doxorubicin in male Wistar rats: involvement of kidney injury molecule-1. AKI, MDA, MPO, PCR, TAC
68  2021 Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell. ---
69  2021 Anticancer potential of (-)-epicatechin in a triple-negative mammary gland model. AMPK, EC, TNBC
70  2021 Anticancer, Free Radicals, and Digestive Enzyme Inhibitory Activities of Rubus sanctus Schreb Root Four Solvent Fractions. PI, RS, RS, RS
71  2021 Antioxidant Effects of Aerobic Training and Crocin Consumption on Doxorubicin-Induced Testicular Toxicity in Rats. GPx, PC, TAC
72  2021 Antioxidant, anti-inflammatory, and anti-apoptotic effects of crocin against doxorubicin-induced myocardial toxicity in rats. CAT, CK-MB, cTnI, i.p, LDL, MDA, MHDS, SOD, TAS, TG, TOS, VLDL
73  2021 Apigenin ameliorates doxorubicin-induced renal injury via inhibition of oxidative stress and inflammation. alpha-SMA, APG, BUN, FN, IL-18, MDA, NLRP3, ROS, RT-PCR, SCr, SOD, TNF-alpha
74  2021 Aptamer Functionalized Upconversion Nanotheranostic Agent With Nuclear Targeting as the Highly Localized Drug-Delivery System of Doxorubicin. UCNPs
75  2021 Aptamers with Self-Loading Drug Payload and pH-Controlled Drug Release for Targeted Chemotherapy. Apt-TNM-DOX, TNM
76  2021 Assessment of the Cytotoxicity of Peptide Modifications of Doxorubicin on Tetrahymena pyriformis. ---
77  2021 Attenuation of doxorubicin-induced oxidative damage in rat brain by regulating amino acid homeostasis with Astragali Radix. AA, AR
78  2021 Autophagy Modulation and Synergistic Therapy to Combat Multidrug Resistance Breast Cancer Using Hybrid Cell Membrane Nanoparticles. MDR
79  2021 Azithromycin enhances the cytotoxicity of DNA-damaging drugs via lysosomal membrane permeabilization in lung cancer cells. AZM, KO, LMP, NSCLC
80  2021 B7-H3 suppresses doxorubicin-induced senescence-like growth arrest in colorectal cancer through the AKT/TM4SF1/SIRT1 pathway. CRC
81  2021 Babao Dan Reverses Multiple-Drug Resistance in Gastric Cancer Cells via Triggering Apoptosis and Autophagy and Inhibiting PI3K/AKT/mTOR Signaling. 3-MA, BBD, CQ, MDR, PI, Rho123
82  2021 Benazepril hydrochloride protects against doxorubicin cardiotoxicity by regulating the PI3K/Akt pathway. ACEIs, HCl, LDH
83  2021 Berberine ameliorates doxorubicin-induced cognitive impairment (chemobrain) in rats. BBR, BDNF, CREB, MnSOD, PGC-1alpha, SIRT1, TNF-alpha
84  2021 Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo. Ber, MDR
85  2021 Biodegradable copper-metformin nanoscale coordination polymers for enhanced chemo/chemodynamic synergistic therapy by reducing oxygen consumption to promote H2O2 accumulation. CDT, Met, NADPH, ROS, SOD, TME
86  2021 Biodegradable Implants Combined with Immunogenic Chemotherapy and Immune Checkpoint Therapy for Peritoneal Metastatic Carcinoma Postoperative Treatment. aPD-1, CRS, HIPEC, Odex, PMC
87  2021 Biological evaluation of mitochondria targeting small molecules as potent anticancer drugs. ATP, ROS
88  2021 Biomimetic "Nanoplatelets" as a Targeted Drug Delivery Platform for Breast Cancer Theranostics. CNs, FL, PA, PFP, PLGA, PLT, US
89  2021 Biomimetic co-assembled nanodrug of doxorubicin and berberine suppresses chemotherapy-exacerbated breast cancer metastasis. Ber, EMT
90  2021 Biomimetic Nanoscale Erythrocyte Delivery System for Enhancing Chemotherapy via Overcoming Biological Barriers. Ang2, ECM, NE, RES
91  2021 Biomimetic nanotherapy: core-shell structured nanocomplexes based on the neutrophil membrane for targeted therapy of lymphoma. MSNs, NHL, Nm, SM, TME
92  2021 Bioreductive Activation of Antitumour Drugs, Doxorubicin and Pirarubicin, Does Not Affect Their Ability to Induce Apoptosis of Sensitive and Multidrug Resistant Leukaemia HL60 Cells. MDR, PIRA
93  2021 Blood circulation stable doxorubicin prodrug nanoparticles containing hydrazone and thioketal moieties for antitumor chemotherapy. DLS, HYD, mPEG, ROS, TK
94  2021 Bone marrow mesenchymal stem cells and their derived exosomes resolve doxorubicin-induced chemobrain: critical role of their miRNA cargo. BMSCs
95  2021 Bone targeting nano-aggregates prepared from self-assembled polyaspartamide graft copolymers for pH sensitive DOX delivery. ALN, HYD, PASPAM, PSI
96  2021 Breast Cancer Inhibition by Biosynthesized Titanium Dioxide Nanoparticles Is Comparable to Free Doxorubicin but Appeared Safer in BALB/c Mice. DLS, FTIR, NPs, ROS, SEM, TEM, UV-vis, XRD
97  2021 By restoring autophagic flux and improving mitochondrial function, corosolic acid protects against Dox-induced cardiotoxicity. CRA, i.p, NS, TFEB
98  2021 CaCO3-Assisted Preparation of pH-Responsive Immune-Modulating Nanoparticles for Augmented Chemo-Immunotherapy. aNLG919, DNCaNPs, ICD, IDO1, TME
99  2021 Calycosin attenuates doxorubicin-induced cardiotoxicity via autophagy regulation in zebrafish models. AIC, CA
100  2021 Cancer Cell-Membrane Biomimetic Boron Nitride Nanospheres for Targeted Cancer Therapy. BNs